Developmental Research Program

摘要 NU-CHERS发展研究计划（DRP）将作为新的，尖端的， 和妇科癌症差异的竞争性转化研究。以下列主题为中心： 在检测、诊断和治疗中促进健康公平的当代转化方法 在妇科癌症方面，DRP将确定并资助利用创新临床和 翻译研究的概念和方法，属于DRP的主题。这些研究项目将 在赠款计划的几乎所有方面的培育下，将得到持续的职业发展的支持。 在DRP下的编程，并将准备好寻求更大规模的校外资金或提交作为 P50 SPORE下的一个完整的研究项目，专注于妇科癌症的差异。DRP联合董事 我将与整个赠款计划的所有领域合作，包括与妇科生物标本的互动 病理学和管理核心，用于技术咨询和生物标本获取以及所有潜在 申请人和获奖者;领导理事会，内部咨询委员会和社区咨询委员会， 新项目的审查和资助;以及领导理事会、内部咨询委员会和外部 咨询委员会，负责对正在进行的供资减少灾害风险方案试点项目进行评价。DRP具体目标1：通过 项目范围内的协调，通过建立基础设施、流程和方向来建立研究能力 建立SPORE试点资助机制，以促进临床和基础科学研究的高影响力创新 关注妇科癌症的差异。DRP获奖者的一个中心重点将是进行 新的转化研究，这是高风险高回报，这和未来的孢子赠款。DRP具体目标2： 为早期和成熟的调查人员建立并支持职业提升管道，以提高 或者将他们的职业生涯重新聚焦于妇科癌症差异焦点的转化研究。我们将利用 并促进内部和外部SPORE教师，研究， 项目接受者、社区诊所领导和社区成员。DRP具体目标3：跟踪和 评估DRP研究项目的成功，以确保进一步推进全面健康公平P50 SPORE和其他校外供资机制。我们将利用已建立并经过测试的评估流程 和方法，以确保所有项目团队在未来的研究工作中取得成功，最终 目标是为解决妇科癌症的分子方法做出有价值的贡献奠定基础 P50 SPORE下的差异。

ABSTRACT The NU-CHERS Developmental Research Program (DRP) will serve as the incubator for novel, cutting edge, and competitive translational research of gynecologic cancer disparities. Centered on the theme of Contemporary Translational Approaches to Advancing Health Equity in the Detection, Diagnoses, and Treatment of Gynecologic Cancers, the DRP will identify and fund research pilot projects that utilize innovative clinical and translational research concepts and approaches that fall under DRP’s theme. These research projects will be nurtured by nearly all facets of the grant program, will be supported by ongoing career enhancement programming under the DRP, and will be well poised to seek larger-scale extramural funding or be submitted as a full research project under a P50 SPORE focused on gynecologic cancer disparities. The DRP Co-Directors will work with all areas of the overall grant program, including interacting with the Gynecologic Biospecimen Pathology and Administrative Cores for technical consult and biospecimen access and triage for all potential applicants and awardees; the Leadership Council, Internal Advisory Board, and Community Advisory Board for the review and funding of new projects; and the Leadership Council, Internal Advisory Board, and External Advisory Board for the ongoing evaluation of active funded DRP pilot projects. DRP Specific Aim 1: Through program-wide coordination, build research capacity by establishing the infrastructure, processes, and direction for a SPORE pilot funding mechanism to foster high-impact innovation in clinical and basic science research focused on gynecologic cancer disparities. A central focus of DRP award recipients will be the ability to conduct novel translational research that is high-risk high-payoff to this and future SPORE grants. DRP Specific Aim 2: Establish and support a career enhancement pipeline for early-stage and established investigators to enhance or refocus their career on translational research with a gynecologic cancer disparities focus. We will leverage and foster interdisciplinary and diverse collaborations between internal and external SPORE faculty, research project recipients, community clinic leadership, and community members. DRP Specific Aim 3: Track and evaluate the success of the DRP research projects to ensure further advancement in a full health equity P50 SPORE and other extramural funding mechanisms. We will utilize established and tested evaluation processes and methods to ensure all project teams are optimized for success in future research endeavors, with the ultimate goal of setting the stage for valuable contributions in molecular approaches to tackling gynecologic cancer disparities under a P50 SPORE.